Sam Freyaldenhoven, MD, MS
Sam Freyaldenhoven, MD, MS
Specialty: Thoracic Surgery
Program: Thoracic Oncology
Language(s): English
-
Overview
Cancer Focus:
Lung Cancer, Mesothelioma, Pancoast TumorDr. Freyaldenhoven received his MD degree from the University of Arkansas for Medical Sciences College of Medicine, where he also earned his MS in biochemistry and molecular biology. He completed a Research Fellowship at Brigham and Women’s Hospital, Division of Thoracic and Cardiac Surgery; then he completed a General Surgery Residency at the University of South Florida. Dr. Freyaldenhoven most recently completed a Clinical Fellowship at Brigham and Women’s Hospital, Division of Thoracic and Cardiac Surgery. Dr. Freyaldenhoven’s clinical interests focus on providing individualized care for patients with thoracic cancers, leveraging advanced surgical techniques and therapies, and collaborating with multidisciplinary teams to ensure optimal outcomes and patient satisfaction. His research focus is on patient-centered clinical investigation, with a specific emphasis on enhancing treatments and outcomes.
-
Publications
- Freyaldenhoven ST, Tsukada H. Robotics in the diagnosis and staging of lung cancer. J Surg Oncol. 2023 Feb.127(2):258-261. Pubmedid: 36630090.
- Lapidot M, Mazzola E, Freyaldenhoven S, De León LE, Jaklitsch MT, Bueno R. Postoperative Empyema After Pleurectomy Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2022 Oct.114(4):1214-1219. Pubmedid: 34619137.
- Lapidot M, Gill RR, Mazzola E, Freyaldenhoven S, Swanson SJ, Jaklitsch MT, Sugarbaker DJ, Bueno R. Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients. Ann Surg. 2022 Jun.275(6):1212-1220. Pubmedid: 33278174.
- Rodriguez M, Dezube AR, Bravo-Iniguez CE, Fox S, De León LE, Tarascio J, Freyaldenhoven S, Mentzer SJ, Swanson SJ, Bueno R, Rochefort MM, Marshall MB, Jaklitsch MT. Impact of Neoadjuvant Chemoradiation on Adverse Events After Bronchial Sleeve Resection. Ann Thorac Surg. 2021 Sep.112(3):890-896. Pubmedid: 33171174.
- De Rienzo A, Chirieac LR, Hung YP, Severson DT, Freyaldenhoven S, Gustafson CE, Dao NT, Meyerovitz CV, Oster ME, Jensen RV, Yeap BY, Bueno R, Richards WG. Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma. J Pathol. 2021 Jan.253(1):68-79. Pubmedid: 32944962. Pmcid: PMC7756745.
- De León LE, Bravo-Iñiguez CE, Fox S, Tarascio J, Freyaldenhoven S, Lapidot M, Jaklitsch MT, Bueno R. Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 Oct.160(4):1064-1073. Pubmedid: 32113716. Pmcid: PMC7390678.
- Lapidot M, Freyaldenhoven S, Bueno R. New concepts in the treatment of malignant pleural mesothelioma. J Thorac Dis. 2018 Mar.10(3):1283-1285. Pubmedid: 29708159. Pmcid: PMC5906329.
- Ziu E, Mercado CP, Li Y, Singh P, Ahmed BA, Freyaldenhoven S, Lensing S, Ware J, Kilic F. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol. 2012 May.52(5):1112-1121. Pubmedid: 22366712. Pmcid: PMC3327821.
-
Patient Comments
115 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments